Aequus Announces Issuance of Stock Options
08 déc. 2020 21h13 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides Third Quarter 2020 Financial Highlights
30 nov. 2020 09h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Anne Stevens’ Leadership Change
12 nov. 2020 20h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and...
Aequus Receives Approval for New ‘Evolve - Daily Intensive’ Lubricating Eye Drops in Canada
29 oct. 2020 08h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Receives Approval for New ‘Evolve - Intensive Gel’ Lubricating Eye Drops in Canada
19 oct. 2020 08h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada
16 oct. 2020 08h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today that it has agreed to an extension...
Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product
22 sept. 2020 09h37 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Announces Filing of New Medical Device License for Evolve Dry Eye Products in Canada
14 sept. 2020 12h50 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today...
Aequus Prepares for Health Canada Regulatory Filing as Partner Receives MDSAP Certificate for Dry Eye Products
31 août 2020 08h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides General Update and Second Quarter 2020 Financial Highlights
27 août 2020 21h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...